Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
15,046
+11,241
+295% +$1.32M 0.18% 47
2026
Q1
$461K Buy
3,805
+108
+3% +$12.5K 0.18% 126
2025
Q4
$392K Buy
3,697
+23
+0.6% +$2.16K 0.04% 132
2025
Q3
$311K Buy
3,674
+127
+4% +$10.5K 0.03% 136
2025
Q2
$284K Hold
3,547
– – 0.03% 93
2025
Q1
$321K Hold
3,547
– – 0.16% 85
2024
Q4
$356K Hold
3,547
– – 0.17% 99
2024
Q3
$406K Buy
+3,547
New +$421K 0.21% 82

Other funds holding MRK

Three Seasons Wealth's MRK Position: Q2 2026 in Review

Three Seasons Wealth increased its Merck (MRK) stake by 295% in Q2 2026, buying an estimated $1.32M and bringing the position to 15,046 shares worth $1.93M. The position accounts for 0.18% of the portfolio, ranked #47.

Three Seasons Wealth first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Three Seasons Wealth held 15,046 shares of Merck worth $1.93M as of Q2 2026.
  • Three Seasons Wealth bought 11,241 Merck shares in Q2 2026, an estimated $1.32M.
  • Merck made up 0.18% of Three Seasons Wealth's portfolio in Q2 2026, its #47 holding.
  • Three Seasons Wealth first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Three Seasons Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.